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ABSTRACT
Intestinal microbiota affects many aspects of physiological processes. The type of microbiota in the early stages of life is 
a critical element conditioning the development of the immune response and food tolerance. Disturbed colonization of 
the digestive tract resulting from the amount or diversity of bacteria colonies stimulates an inflammatory response that 
is associated in later life with inflammatory and autoimmune diseases. One of the elements disturbing normal coloniza-
tion in the perinatal period is the operative way of delivery by caesarean section and the administration of antibiotics, 
used as a prophylactic measure as well as for therapeutic reasons. Based on the current state of knowledge, there is a lot 
of evidence demonstrating the long-term adverse effects of these modifying agents for gut microbiota, which should be 
kept to a minimum as far as possible.
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INTRODUCTION 
In recent years, increasing attention has been focused 
on disorders of newborn gut colonization and their impact 
on its further development and functioning in adulthood, 
however, these data are largely not systematized. Initial 
microbial colonization is one of the most important fac-
tors affecting a child’s development having a significant 
impact on triggering of diseases in his adult life. Such dis-
orders as diabetes, obesity, allergies, inflammatory bowel 
diseases and other autoimmune disturbances are found to 
be linked with abnormal colonization during the first two 
years of life, that commence since the perinatal period. 
Epigenetic changes may induce transgenerational issues 
with fixation of mutant genes, which functional products 
have effect in subsequent generations. The perinatal fac-
tors that impair proper newborn’s gut colonization include 
caesarean section, use of antibiotics during pregnancy 
and delivery, among others, as a prevention of GBS in-
fection, as well as early abandonment of breastfeeding 
replaced by formula feeding. A recent significant increase 
in both the incidence of surgical deliveries as well as use 
of antibiotic therapy have become the reason for more 
and more frequent researches on the negative impact of 
these procedures.
THE COLONIZATION OF THE FETUS IN UTERO
The degree of sterility of the fetal environment and the 
possibility of transfer of the microbiome to the uterine cav-
ity have been the subject of scientific discussion for a long 
time. For many years, it was believed that the fetal amni-
otic environment would remain sterile until the premature 
rupture of membranes had place during the delivery and 
that the intestinal tract of the newborn remain sterile until 
birth. According to the above paradigm, the first contact of 
a child with bacteria occurs through the vertical (from the 
mother) and horizontal (from the environment) way, and the 
first signs of bacterial colonization can be recognized only 
a few hours after delivery [1]. The implementing and use 
of highly specialized methods for microbial identification, 
including polymerase chain reaction (PCR), undermined 
the theory mentioned above and allowed for precise deter-
mination of the microbiota of the fetal environment [2–4]. 
A modified PCR technique, i.e. PCR-DGGE (polymerase chain 
reaction — denaturing gradient gel electrophoresis) is used 
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to assess bacterial DNA and the 16S rRNA sequence in the 
material being examined (e.g. stool, placenta, amniotic fluid, 
meconium). The presence of bacteria in placental tissue, 
umbilical cord and meconium was confirmed, proving the 
physiological contact of the fetus with microbiota [2]. In 
several investigations it is reported that intrauterine colo-
nization of the fetus plays a pivotal role in the maturation 
of the immune system and has a significant impact on its 
development in the neonatal, childhood and ultimately in 
adulthood [5]. Sodeborg et al. [6] showed a relationship be-
tween disturbed bacterial colonization in pregnant women 
complicated by obesity and diabetes, with excessive birth 
weight of their newborns, abnormal fat distribution, over-
weight, immune-related dysfunction and the presence of 
non-alcoholic fatty liver in their adult life. Studies confirming 
the association between abnormal intestinal colonization 
and autism in children have been also published [7]. If the 
“hypothesis of in utero colonization” would prove to be 
correct, the role of the primary microbiome, environment, 
lifestyle and clinical factors determining human health as 
well as regulatory epigenetic aspects should be redefined 
[8]. As consequence of this assumption the clinical activi-
ties promoting proper colonization with correct transfer of 
microbiota in pregnant women with among others reducing 
the incidence of cesarean sections should be implemented 
[1]. Human microbiota shows an individual variability, deter-
mined by the number and diversity of bacterial strains. Dur-
ing pregnancy, microbes and metabolites of the microbiome 
are transferred to the fetus and then to the newborn during 
labor and lactation [9]. The composition of the microbiome 
is moderated by the environment, including diet, pregnancy 
health, metabolic diseases, gestational weight gain, termina-
tion of pregnancy, genetic factors and antibiotics used in 
the perinatal period [10–12].
The native intestinal microflora differs in women with 
normal body weight and obesity. Pregnant women with 
excessive weight gain have shown an increase in Firmicutes 
(Staphylococcus) and some Proteobacteria (Escherichia 
coli), especially in the second half of pregnancy [12, 13]. It 
has been shown that differences in microbiota species in 
pregnancy determine the increased birth weight of new-
borns [10, 12]. One of the factors affecting the developing 
fetus in obese women is the excessive amount of plasma 
endotoxins, the complex lipopolysaccharides (LPS) form-
ing an inherent fraction of the outer cell wall of bacteria. 
Endotoxins may increase the intestinal translocation of bac-
terial products across the intestinal mucosa, contributing 
to the formation of an inflammatory response within the 
placenta and insulin resistance. Collado et al. [2], using the 
16S rRNA sequencing method to identify bacterial species in 
amniotic fluid and placental tissue samples, found that the 
most common strain was the bacteria belonging to the Pro-
teobacteria group, especially from the Enterobacteriaceae 
family (genera Escherichia and Shigella). The presence of the 
same microorganisms has been also identified in fetal ver-
nix caseosa, meconium and faeces of newborns, although 
their growth was less abundant. Propionibacterium, in turn, 
was the second most common strain that has been found 
in placental tissue, amniotic fluid and meconium as well. 
Other bacterial strains have been also shown to be pre-
sent, although in a much smaller quantity (Streptococcus, 
Staphylococcus, Lactobacillus) [3, 11].
EARLY BACTERIAL COLONIZATION OF THE 
NEWBORN AFTER BIRTH
According to Langherdries et al. [11], the postnatal con-
tact of a newborn baby with an invasive microbiological 
environment and exposure to the new antigens, intestinal 
bacteria and their products, triggers immune mechanism 
within the intestinal tissues. It is likely that the modification of 
the quality of the host bacteria and their interaction leads to 
disturbed colonization, favoring the acquisition of abnormal 
immunity of neonates and an appearance of autoimmune 
and allergic diseases in later life. Various environmental fac-
tors occurring in the early neonatal period may affect the 
intestinal bacterial composition, potentially affecting the 
subsequent risk of diseases such as asthma, metabolic dis-
orders and inflammatory bowel diseases [14]. The intestinal 
microbiome and adaptive immunity of infant is controlled 
by innate lymphoid cells (ILCs), which play an important role 
in coordination the inflammation, immunity, wound healing, 
and tissue homeostasis [15]. The above observations par-
ticularly apply to developing countries. Therefore, it should 
be recognized that the composition of the intestinal flora 
determines the type of immune response and the change in 
the profile of the intestinal flora, the so-called dysbiosis pre-
cedes the development of allergies in later life of infants. The 
mechanism responsible for the regulatory effect of a micro-
biota on the body is the ability to change gene expression 
in the host gut via the gut flora. Bacteria mainly colonize 
the large bowel, forming colonies containing an average of 
1011 CFU (Colony Forming Unit) in 1 gram of tissue tested. 
Their content during life does not change much in healthy 
individuals, provided that there are no infectious diseases 
and antibiotic therapy. The anaerobic microflora as the most 
important is represented in 80% by strains of the genera: 
Bacteroides, Eubacterium, Bifidobacterium, Peptostrepto-
coccus. The factor initiating colonization of the intestine is 
a direct contact with maternal rectovaginal flora during deliv-
ery, followed by breastfeeding [1, 4, 16]. Usually this process 
lasts several weeks. During the first 48 hours, the number 
of bacterial cells is already very high, 104–106 CFU/mL of 
intestinal content, and is independent of how the neonate 
is fed. During this period, antibiotic therapy is a factor that 
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significantly disturbs the quality and quantity of colonizing 
bacteria. Over the next 10 days, an increase in Bifidobacteria 
and Lactobacillus bacteria number is observed, achieving 
a stable concentration of approximately 109 CFU/mL of intes-
tinal content. In the next phase of colonization, an increase in 
Escherichia coli, Bacteroides spp and a much less significant 
increase in Clostridiae are detected. In nonphysiological con-
ditions during the perinatal period, it is the Clostridia strains 
that show the strongest positive association with increased 
neonatal morbidity [11, 12, 17]. At the end of the first month 
of life, there are differences in the type of bacterial colony, 
depending on how the newborn is fed. In the breast-fed 
babies’ group, the intensive intestinal growth relates to the 
Bifidobacteria colony, compared with only 30–40% bacterial 
content in formula-fed babies. By the end of the first and up 
to the second year of life, the content of intestinal microflora 
is approaching that in adulthood.
THE GUT MUCOSAL IMMUNE SYSTEM
A particularly important element of acquired immunity 
is the intestinal mucosa barrier. Commensal intestinal mi-
croflora determines the functions of lymph tissue, occurring 
within the gastrointestinal tract, the so-called GALT (gut-as-
sociated lymphoid tissue) by transmitting information to en-
terocytes and M cells of the intestinal lymphoid epithelium. 
The GALT system fulfills a dual role: it induces an immune 
system against bacterial pathogens and viruses through 
an enhanced, well-controlled pro-inflammatory response 
and increases complex immune mechanisms that produce 
antigen tolerance [12]. The initial colonization of gut micro-
organisms depends on the GALT maturation and is regulated 
by the Gastrointestinal-Blood Barrier (GIB) throughout selec-
tive absorption to the blood as well. The establishment of 
a balance between immunity and infections is determined 
by GALT and critical closure of GIB. Enterocytes, belonging 
to the major histocompatibility complex (MHC), can partially 
transfer information about the type of antigen, thus fulfill-
ing the role of the first mucosal immunity mechanism. The 
interaction of enterocytes with endothelial T lymphocytes, 
mainly CD8 + (cytotoxic T lymphocytes) is of fundamental 
importance here. The degree of neonatal intestinal maturity 
varies individually and shows differences depending on 
the week of gestation [18]. Although the human intestine 
reaches structural maturity around 19 weeks of pregnancy 
and all cellular elements of the intestinal immune system 
are already present, its functional full maturity occurs after 
the onset of antigenic stimulation with colonizing microflora 
[18]. Studies have shown that premature exposure of the 
fetal intestine to microorganisms contained in the amniotic 
fluid may be associated with premature birth [19]. Also, the 
exposure of a pregnant woman’s body to bacteria may affect 
the development and maturation of the fetal epithelium of 
the intestine, which in turn promotes its hypersensitivity to 
pro-inflammatory factors, leading, among others to necrotic 
enterocolitis in a newborn [20]. Newborns during labor are 
exposed to maternal bacteria of the vagina and anus mu-
cosa, which are mainly facultative anaerobes, Streptococci 
[18]. Within a few days, Enterococci and enterobactriac-
eaea appear, whose activity is associated with a decrease in 
oxygen concentration, thus facilitating further colonization 
with Bifidobacteria and Bacteroides spp. and Clostridium 
spp. Exposure of the nascent baby to ligands of colonizing 
bacteria seems to be a key factor developing an intestinal 
tolerance . Bacterial ligands are recognized by innate im-
mune receptors, Toll like Receptors (TLRs), whose expression 
is present in fetal, neonatal and adult life. TLR2 and TLR4 are 
present in the fetal intestinal epithelium since the 18th 
week of gestation [21]. As a result of receptors activation 
that occurs throughout the contact of newborn’s intestinal 
epithelial cells with LPS, an endotoxin present in the outer 
membrane of Gram-negative bacteria, the immunotoler-
ance process develops [22]. Perinatal contact of bacterial LPS 
with fetal epithelial TLR induces the production of microRNA 
(miR) -146a, which in turn inhibits the translation of inter-
leukin-1 receptor-associated kinase (IRAK-1), a key enzyme 
in the TLR4 metabolic pathway. Low IRAK-1 concentration 
protects the intestine during the first contact with bacteria. 
After recognition of microorganisms by a newborn’s intesti-
nal epithelium, it also begins to produce cytokines such as 
interleukin-10 (IL-10) and transforming growth factor beta 
(TGF-β), which have immunoregulatory properties. Among 
the secreted molecules responsible for determining micro-
biological tolerance homeostasis, the peptides defensin 
(alpha and beta) and cathelicidin play an important role. In 
other words, there are antimicrobial peptides that regulate 
commensal flora and protect against pathogens. Located 
in the small intestinal crypts, Paneth cells produce large 
amounts of alpha defensin, an antimicrobial peptide which 
accounts for over 70% of their secretory bactericidal activ-
ity. In turn, beta defensins are mainly present in the large 
intestine. In contrast, cathelicidins are peptides expressed 
in the intestinal epithelium and produced by various intes-
tinal cells, including neutrophils, mast cells, and epithelial 
cells. The bactericidal activity of these cationic peptides is 
associated with their amphipathic properties. Endogenous 
cathelicidin affects the intestinal barrier integrity and modu-
lates the infiltration of neutrophils and macrophages during 
infection and bacterial sepsis [23].
MODE OF DELIVERY 
One of the factors disturbing the proper colonization of 
the newborn’s intestine is an operative delivery by caesar-
ean section [17, 24]. Differences in newborns’ gut microbiome 
content and diversity on the 4th and 120th day after delivery 
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have been shown, suggesting that the composition of the 
so-called early postpartum microbiota determines the micro-
biota during the subsequent years. The changes in gut bacte-
ria populations diversity, however, largely disappear after six 
months of life of the infant. [24]. In case of caesarean section 
delivery, colonization of the newborn’s intestine seems to 
occur later in relation to infants born by vaginal route. Many 
studies have also shown that microbiota of newborns after 
caesarean section differs from that of delivered by vaginal 
route [25, 26]. In an animal model, it was demonstrated that 
the initial bacterial flora of newborns is mainly composed of 
microorganisms of the rectovaginal origin of mothers [18]. In 
the case of neonates after caesarean section, the dominant 
colonizing microorganisms are Staphylococcus and Propi-
onibacterium, derived from the mother’s skin. On the other 
hand, vaginal birth is associated with colonization mainly by 
Lactobacillus and Prevotella strains occurring in the female 
urogenital area [3]. The most efficient colonization of a baby, 
therefore, occurs along with its inoculation with vaginal dis-
charge microbiota during childbirth. During childbirth, the 
baby is also colonized by maternal digestive tract bacteria 
[27]. It is likely, that operative way delivery seems to be as-
sociated with a higher incidence of asthma, inflammatory 
bowel disease and obesity in adulthood through disturbed 
colonization of the neonate leading to dysbiosis [2]. Other 
factors affecting the development of a newborn microbiota 
are also the duration of pregnancy, diet during pregnancy, 
breastfeeding, genetic and environmental conditions. 
PERINATAL ANTIBIOTIC THERAPY
Exposure to antibiotics is associated with their destruc-
tive effects on the intestinal bacterial flora. The implemen-
tation of both early short-term and prolonged antibiotic 
therapy may be associated with an increased risk of being 
overweight or obese in late childhood as well as other fat 
accumulation related disturbances [28]. The use of anti-
biotic therapy during labor in women GBS positive preg-
nant women as a prevention of infectious complications 
in newborns, including sepsis, significantly disturbs the 
microbial balance of the rectovaginal region, impairing 
the proper colonization of the newborn during delivery 
[29]. Also, pregnancy exposure to antibiotic therapy used in 
both premature babies and full-term children significantly 
affects the composition of the microbiota of newborns, 
increasing the risk of early neonatal sepsis [29]. The effect 
of perinatal antibiotic therapy inducing maternal vaginal 
and infant gut microbiota dysbiosis, is a significant decrease 
in the number of Lactobacillus spp. In Fouhy F. et al. [30] 
study, carried out in nine full-term newborns treated with 
ampicillin and gentamicin, the exposure to antibiotics was 
associated with an increase in growth of Proteobacteria 
colony and decrease of Actinobacteria in faeces, especially 
of Bifidobacterium species within four weeks, compared 
to unexposed for antibiotics newborns. According to Zhou 
et al. [29], the neonates born at term without antibiotic expo-
sure showed no early sepsis, while in the group of neonates 
born at term or prematurely exposed to antibiotic therapy 
before labor, early-onset sepsis has been diagnosed in at 
least one case. Therefore, antibiotics routinely used in the 
perinatal period may cause gut dysbiosis, resulting in both 
short- and long-term diseases. Early empirical antibiotics 
in newborns increase the risk of necrotizing enterocolitis 
(NEC) and late-onset sepsis (LOS) in premature babies, while 
maternal intrapartum antibiotic prophylaxis (IAP) is associ-
ated with inflammatory bowel diseases, obesity and atopic 
diseases in infants [31]. Antibiotics have a negative impact 
on the homeostasis of the pregnant woman’s microbiota, 
while the use of properly selected probiotics has a beneficial 
effect on both pregnant women and their offspring. In order 
to prevent metabolic complications and in the case of thera-
peutic intervention, it is recommended to use good-quality 
pre- and probiotics in combination with an individually 
selected, high-nutritious diet [32]. The use of antibiotics 
during the first half of a child’s life is associated with system-
atic excessive weight gain at a later time, while this effect is 
noticeable when women took medicine in the second and 
third trimester of pregnancy, as this correlation has not been 
seen in the first trimester of pregnancy. The consequences 
of taking antibiotics were still visible in children in the age 
of two years [33, 34]. The type and duration of antibiotic 
administration is important in the context of the effects on 
the pregnant women microbiota and the development of 
the child’s immune tolerance. For this reason, according to 
the researchers, the use of antibiotics should remain under 
strict control, not only because of the possibility of the 
evolution of antibiotic-resistant microorganisms, but also 
because of the long-term metabolic consequences [28].
SUMMARY
According to the current state of knowledge, preliminary 
microbiotic colonization begins before the onset of labor 
and the microbiota derived from the amniotic fluid, placenta 
and maternal intestine may support its development in the 
infant. There are perinatal factors connected with a higher 
risk of impairing infants and children health, such as expo-
sure to antibiotics and cesarean section. These two factors 
seem to be extremely important and may have a destructive 
impact on the infants’ microbiota, leading to dysbiosios and 
subsequent health disorders. The presence of Lactobacillus 
and Bifidobacteria species reduces the risk of intestinal in-
flammation, while the Firmicutes/Bacteroides strains growth 
increases the risk of type 2 diabetes, overweight, obesity 
and lipid disorders, which is particularly visible in premature 
babies. The gut of infants born by cesarean section are mostly 
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colonized by environmental skin bacteria with decreased di-
versity. Also, cesarean section results in delayed colonization, 
leading to weaken beneficial immunomodulatory signals.
It is extremely important for both women and physi-
cians to be aware of the harmful use of antibiotic therapy 
in unjustified cases, as well as the use of cesarean section in 
conditions where there are no obstetric contraindications 
to terminate pregnancy by nature. The use of antibiotics 
should remain under strict control, not only because of the 
possibility of the evolution of antibiotic-resistant micro-
organisms, but also because of the long-term metabolic 
consequences. Considering the above facts may contribute 
to reducing the incidence of lifestyle diseases.
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